Millipore Sigma Vibrant Logo

MABE362 Anti-EZH2 Antibody, clone AE25

View Products on Sigmaaldrich.com
MABE362
100 µL  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Offres spéciales

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Offres spéciales

      Tableau de caractéristiques principal

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HWB, IHCMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABE362
      Replaces04-1047
      DescriptionAnti-EZH2 Antibody, clone AE25
      Alternate Names
      • Enhancer of zeste homolog 2
      • Lysine N-methyltransferase 6
      • enhancer of zeste 2
      • histone-lysine N-methyltransferase EZH2
      Background InformationEZH2 (enhancer of zeste homologue 2), also known as Enx1, is a member of the polycomb group of proteins and is involved in cell cycle regulation. EZH2 represses transcription via trimethylation of histone H3 on Lys27 (H3K27) as indicated by the fact that RNAi-mediated knockdown of EZH2 resulted in a loss of H3K27 trimethylation. EZH2 is ubiquitously expressed during early embryo genesis, and becomes restricted to the central and peripheral nervous systems and sites of fetal hematopoiesis during later development. In the adult, EZH2 is restricted to the spleen, testis, and placenta. EZH2 and BMI-1 genes are coexpressed in Reed-Sternberg cells of Hodgkin’s disease. Coexpression of BMI-1 and EZH2 is also associated with cycling cells and degree of malignancy in B-cell non-Hogkin’s lymphoma. EZH2 is involved in the progression of prostate cancer, and has been identified as a marker of aggressive breast cancer. Two transcript variants encoding distinct isoforms have been identified for this gene.
      References
      Product Information
      FormatPurified
      Control
      • T47D cell lysate
      PresentationPurified mouse monoclonal IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationThis Anti-EZH2 Antibody, clone AE25 is validated for use in Western Blotting, IHC for the detection of EZH2.
      Key Applications
      • Western Blotting
      • Immunohistochemistry
      Application NotesWestern Blot Analysis: A 1:500 dilution from a representative lot detected EZH2 in Jurkat and HeLa cell lysates.

      Immunohistochemistry Analysis: A representative lot detected EZH2 in breast carcinoma tissue (Pietersen et al., 2008)
      Biological Information
      ImmunogenMBP-tagged recombinant protein corresponding to human EZH2.
      CloneAE25
      HostMouse
      IsotypeIgG1κ
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • ENX-1
      • KMT6
      Purification MethodProtein G Purified
      UniProt Number
      Molecular Weight~80 kDa observed. Uniprot describes multiple isoforms ranging from 80-86 kDa.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blot in T47D cell lysate.

      Western Blot Analysis: A 1:1000 dilution of this antibody detected EZH2 in 10 µg of T47D cell lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      MABE362 04053252551819

      Documentation

      Anti-EZH2 Antibody, clone AE25 FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-EZH2 Antibody, clone AE25 Certificats d'analyse

      TitreNuméro de lot
      Anti-EZH2, clone AE25 - 2458016 2458016
      Anti-EZH2, clone AE25 - 3472441 3472441
      Anti-EZH2, clone AE25 - 3698189 3698189
      Anti-EZH2, clone AE25 - 4154506 4154506
      Anti-EZH2, clone AE25 - Q2062626 Q2062626
      Anti-EZH2, clone AE25 -2572523 2572523
      Anti-EZH2, clone AE25 -2621117 2621117
      Anti-EZH2, clone AE25 Monoclonal Antibody 3048308
      Anti-EZH2, clone AE25 Monoclonal Antibody 2902715

      Références bibliographiques

      Aperçu de la référence bibliographiqueNº PubMed
      EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.
      Pietersen, Alexandra M, et al.
      Breast Cancer Res., 10: R109 (2008)  2008

      Afficher le résumé
      19099573 19099573

      Produits & Applications associés

      Related Products

      Référence Description  
      05-1319 Anti-EZH2 Antibody, clone BD43 Prix & Disponibilité
      07-1583 Anti-EZH2 (Enhancer of Zeste Homologue 2) Antibody, internal Prix & Disponibilité
      07-689 Anti-EZH2 Antibody Prix & Disponibilité
      17-662 ChIPAb+ EZH2, clone AC22 - ChIP Validated Antibody and Primer Set Prix & Disponibilité

      Catégories

      Life Science Research > Antibodies and Assays > Primary Antibodies